170 related articles for article (PubMed ID: 17413605)
1. CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy.
Bax D; Siersema PD; Moons LM; Dekken Hv; Tilanus HW; Kusters JG; Kuipers EJ
J Clin Gastroenterol; 2007 Apr; 41(4):375-9. PubMed ID: 17413605
[TBL] [Abstract][Full Text] [Related]
2. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
3. Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
Kerkhof M; Bax DA; Moons LM; van Vuuren AJ; van Dekken H; Steyerberg EW; Kuipers EJ; Kusters JG; Siersema PD;
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1613-21. PubMed ID: 17206949
[TBL] [Abstract][Full Text] [Related]
4. Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.
Castillo D; Puig S; Iglesias M; Seoane A; de Bolós C; Munitiz V; Parrilla P; Comerma L; Poulsom R; Krishnadath KK; Grande L; Pera M
J Gastrointest Surg; 2012 Feb; 16(2):227-37; discussion 237. PubMed ID: 22076569
[TBL] [Abstract][Full Text] [Related]
5. Expression of CDX2 and MUC2 in Barrett's mucosa.
Steininger H; Pfofe DA; Müller H; Haag-Sunjic G; Fratianu V
Pathol Res Pract; 2005; 201(8-9):573-7. PubMed ID: 16259110
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.
Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y
Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796
[TBL] [Abstract][Full Text] [Related]
7. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of endoscopic brushing and magnified endoscopy with narrow band imaging (ME-NBI) to detect intestinal phenotype in columnar-lined esophagus.
Murao T; Shiotani A; Yamanaka Y; Kimura Y; Tsutsui H; Matsumoto H; Kamada T; Manabe N; Hata J; Haruma K
J Gastroenterol; 2012 Oct; 47(10):1108-14. PubMed ID: 22576025
[TBL] [Abstract][Full Text] [Related]
9. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
10. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
11. Pediatric columnar lined esophagus vs Barrett's esophagus: is it the time for a consensus definition.
Cohen MC; Ashok D; Gell M; Bishop J; Walker J; Thomson M; Al-Adnani M
Pediatr Dev Pathol; 2009; 12(2):116-26. PubMed ID: 18684017
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells.
Hu Y; Jones C; Gellersen O; Williams VA; Watson TJ; Peters JH
Arch Surg; 2007 Jun; 142(6):540-4; discussion 544-5. PubMed ID: 17576890
[TBL] [Abstract][Full Text] [Related]
13. CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.
Johnson DR; Abdelbaqui M; Tahmasbi M; Mayer Z; Lee HW; Malafa MP; Coppola D
World J Gastroenterol; 2015 Mar; 21(9):2770-6. PubMed ID: 25759548
[TBL] [Abstract][Full Text] [Related]
14. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.
Moons LM; Bax DA; Kuipers EJ; Van Dekken H; Haringsma J; Van Vliet AH; Siersema PD; Kusters JG
J Clin Pathol; 2004 Oct; 57(10):1063-8. PubMed ID: 15452161
[TBL] [Abstract][Full Text] [Related]
15. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.
Lord RV; Wickramasinghe K; Johansson JJ; Demeester SR; Brabender J; Demeester TR
Surgery; 2004 Sep; 136(3):633-40. PubMed ID: 15349112
[TBL] [Abstract][Full Text] [Related]
16. Columnar Metaplasia in the Esophageal Remnant After Esophagectomy: A Common Occurrence and a Valuable Insight Into the Development of Barrett Esophagus.
Dunn LJ; Burt AD; Hayes N; Griffin SM
Ann Surg; 2016 Dec; 264(6):1016-1021. PubMed ID: 26756755
[TBL] [Abstract][Full Text] [Related]
17. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
18. Mucin histochemistry of intestinal metaplasia in Barrett's esophagus.
Jauregui HO; Davessar K; Hale JH; Kessimian N; Cenoz C
Mod Pathol; 1988 May; 1(3):188-92. PubMed ID: 3237699
[TBL] [Abstract][Full Text] [Related]
19. CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus.
Shi XY; Bhagwandeen B; Leong AS
Am J Clin Pathol; 2008 Apr; 129(4):571-7. PubMed ID: 18343784
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.
Jang BG; Lee BL; Kim WH
PLoS One; 2015; 10(5):e0127300. PubMed ID: 25996368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
